Real World Evidence: Presentations

Sunday, 2 November 2014
Toronto, Ontario

Opening and Opening Remarks

• John Sproule, IHE
• Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada
• Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU

PART I: Fit for purpose: When and where is real-world evidence most useful?

• Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital
  Download Presentation
• Panelists:
  Cy Frank, President and CEO, Alberta Innovates Health Solutions
  Greg Zaric, Professor, Ivey Business School
  Elaine Campbell, President, AstraZeneca Canada Inc.

PART II: Guiding principles for its use: What questions do we need to consider?

• Speaker: Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan
  Download Presentation
• Panelists:
  Deborah Marshall, Associate Professor, University of Calgary
  Robyn Tamblyn, Director, Canadian Institutes of Health Research – Institute for Health Services and Policy Research
  Carole McMahon, Patient representative expert, pan-Canadian Oncology Drug Review Expert Review Committee (pERC)

Directed discussion with first session panelists

PART III: Final Thoughts - data access, linkage and public perception of risk.

Moderated discussion with Invited Panelists

Summary of Discussion
Suzanne McGurn, ADM, Ontario MOHLTC

Closing Remarks – Next Steps